{"Title": ["AtriCure Inc (ATRC) Q1 2020 Earnings Call Transcript", "Notable Wednesday Option Activity: TNDM, MU, ATRC", "How The Pieces Add Up: IHI Targets $282", "AtriCure (ATRC) Shares Cross Below 200 DMA", "AtriCure Inc (ATRC) Q4 2019 Earnings Call Transcript", "AtriCure Hits All-time High, What Next?", "AtriCure Inc (ATRC) Q3 2019 Earnings Call Transcript", "Commit To Buy AtriCure At $17.50, Earn 5.1% Annualized Using Options", "AtriCure Inc (ATRC) Q1 2020 Earnings Call Transcript", "Notable Friday Option Activity: HD, IBM, ATRC", "Implied IHI Analyst Target Price: $261", "Notable Two Hundred Day Moving Average Cross - ATRC", "AtriCure Inc (ATRC) Q2 2019 Earnings Call Transcript", "ATRC Crosses Above Key Moving Average Level", "AtriCure Inc (ATRC) Q1 2019 Earnings Call Transcript", "Noteworthy Friday Option Activity: XENT, AFL, ATRC", "AtriCure is Now Oversold (ATRC)", "AtriCure Inc (ATRC) Q4 2018 Earnings Conference Call Transcript", "Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for", "Noteworthy Tuesday Option Activity: SPTN, ATRC, WIN", "AtriCure (ATRC) Upgraded to Strong Buy: Here's What You Should Know", "Notable Thursday Option Activity: LAD, BA, ATRC", "Commit To Purchase AtriCure At $25, Earn 8.6% Annualized Using Options", "Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears", "ATRC Crosses Below Key Moving Average Level", "ATRC Crosses Below Key Moving Average Level", "AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates", "Analysts Anticipate IHI Will Reach $237", "AtriCure (ATRC) Looks Good: Stock Adds 6.8% in Session", "Why Chefs' Warehouse, SMART Global Holdings, and AtriCure Jumped Today", "AtriCure Reaches Analyst Target Price", "Weighing The Week Ahead: Will Strong Economic Data Send Interest Rates Higher?", "Perrigo Plunges on $1.9B Tax Bill From Irish Government", "Perkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ...", "Here's Why ArtiCure, Inc. Is Up Double-Digits Today", "Mid-Morning Market Update: Markets Open Lower; Deutsche Bank Plans to Raise Capital", "First Light Asset Management, LLC Buys Immunomedics, NeoGenomics, Shire PLC, Sells BioScrip, ...", "AtriCure (ATRC): Moving Average Crossover Alert", "Mid-Morning Market Update: Markets Mostly Higher; Mastercard Beats Q3 Views", "Health Care Sector Update for 10/28/2016: EHTH,ATRC,OPXA", "Commit To Buy AtriCure At $12.50, Earn 8.6% Annualized Using Options", "Perkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ...", "Stryker (SYK) Beats on Q1 Earnings & Sales; FY16 View Up", "New Strong Buy Stocks for April 21st", "New Strong Buy Stocks for April 19th", "New Strong Buy Stocks for April 15th", "What Falling Estimates & Price Mean for INSYS Therapeutics (INSY)", "New Strong Buy Stocks for April 12th", "Health Care Sector Update for 10/28/2016: CYTK,ATRC,OPXA", "New Strong Buy Stocks for March 24th", "New Strong Buy Stocks for March 21st", "Phibro Animal Health (PAHC) in Focus: Stock Jumps 5.1%", "New Strong Buy Stocks for March 3rd", "New Strong Buy Stocks for February 29th", "3 MedTech Stocks Poised to Trump Earnings in Q3", "Health Care Sector Update for 10/05/2015: ATRC,CTRV,GILD,SIEN", "New Strong Buy Stocks for March 29th", "AtriCure (ATRC): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape", "Can AtriCure (ATRC) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape", "Zacks Rank #5 Additions for Thursday - Tale of the Tape", "Zacks Rank #5 Additions for Thursday - Tale of the Tape", "AtriCure (ATRC) is Overbought: Is A Drop Coming? - Tale of the Tape", "Zacks Rank #5 Additions for Monday - Tale of the Tape", "Zacks Rank #5 Additions for Wednesday - Tale of the Tape", "AtriCure (ATRC) in Focus: Stock Tumbles 10.2%", "Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape", "Quidel Corp. (QDEL) in Focus: Stock Moves 6.73% Higher - Tale of the Tape", "Alere (ALR) Surges: Stock Moves 12.4% Higher - Tale of the Tape", "Chimerix (CMRX) in Focus: Stock Surges 11.8% - Tale of the Tape", "TG Therapeutics (TGTX) Worth Watching: Stock Up 9.1% - Tale of the Tape", "Zimmer Down to Sell on Falling Estimate Revisions, View Cut - Analyst Blog", "Liberator Medical Holdings (LBMH) Jumps: Stock Gains 6.3% - Tale of the Tape", "Zacks Rank #5 Additions for Monday - Tale of the Tape", "ResMed Introduces AirSense 10 Devices to Treat Sleep Apnea - Analyst Blog", "LeMaitre Vascular Acquires Omniflow II Manufacturer Xenotis - Analyst Blog", "Weakness Seen in Hanger (HGR) Estimates: Should You Stay Away? - Tale of the Tape", "ResMed (RMD) Launches Air Solutions for Improved SDB Therapy - Analyst Blog", "Medtronic Up on Quadripolar Lead, CRT-D Devices' FDA Approval - Analyst Blog", "Hanger Misses on Q2 Earnings and Revenues, Trims Guidance - Analyst Blog", "Falling Earnings Estimates Signal Weakness Ahead for TG Therapeutics (TGTX) - Tale of the Tape", "Covidien's First Technology Center in Brazil, Shares Gain - Analyst Blog", "Alere Q2 Earnings and Revenues Miss, Deteriorate Y/Y - Analyst Blog", "Haemonetics Tops Q1 Earnings and Revenues, Guidance Retained - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Hospira Inc. (HSP) Jumps: Stock Adds 8.3% in Session - Tale of the Tape", "AtriCure (ATRC) Jumps: Stock Adds 6.7% in Session - Tale of the Tape", "Zacks Rank #5 Additions for Thursday - Tale of the Tape", "Zacks Rank #5 Additions for Tuesday - Tale of the Tape", "Symmetry Medical Tops on Earnings & Revenues, Vends OEM Biz - Analyst Blog", "Alere Q2 Earnings and Revenues Miss, Deteriorate Y/Y - Analyst Blog", "Zacks Rank #5 Additions for Thursday - Tale of the Tape", "Healthcare Stocks Adding to Earlier Losses; AtriCure Jumps Nearly 12% After Q3 EPS, Revenue Beats", "Sector Update: Healthcare", "AtriCure Inc. (ATRC) Enters Overbought Territory - Tale of the Tape", "Good News for Hospira, Shares up - Analyst Blog", "Positive Data for COV's Pipeline - Analyst Blog", "Zacks Rank #5 Additions for Friday - Tale of the Tape", "Abbott Progresses with Absorb in Japan - Analyst Blog", "FDA Nod for STJ's Ellipse & Assura - Analyst Blog", "Symmetry Provides Dismal 2013 View - Analyst Blog", "Abbott Labs' HPV Test in Canada - Analyst Blog", "Back to Neutral on Hospira - Analyst Blog", "Covidien's ENB Adopted by ACCP - Analyst Blog", "CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog", "Positive Data for COV's Solitaire - Analyst Blog", "Abbott Progresses with Absorb in Japan - Analyst Blog", "Stryker Reiterated at Neutral - Analyst Blog", "Covidien Prices Senior Notes - Analyst Blog", "CE Mark for STJ's Ellipse & Assura - Analyst Blog", "Stryker Hits New 52-Week High - Analyst Blog", "St. Jude Reiterated at Neutral - Analyst Blog", "Weekly CEO Sells Highlight: Amyris, AtriCure, 3D Systems Corporation and Cooper Tire & ...", "FDA Nod for COV's Advanced Nellcor - Analyst Blog", "Biotech M&A: Analyst Gives 5 Potential Targets in Biomedical Devices"], "Elapsed Time": ["APR 30, 2020", "APR 29, 2020", "APR 29, 2020", "MAR 12, 2020", "FEB 18, 2020", "JAN 30, 2020", "OCT 30, 2019", "OCT 16, 2019", "APR 30, 2020", "AUG 9, 2019", "AUG 6, 2019", "AUG 5, 2019", "JUL 31, 2019", "JUN 25, 2019", "APR 26, 2019", "MAR 15, 2019", "AUG 15, 2019", "FEB 28, 2019", "FEB 21, 2019", "FEB 19, 2019", "JAN 31, 2019", "JAN 17, 2019", "JAN 4, 2019", "DEC 27, 2018", "MAR 4, 2019", "DEC 20, 2018", "NOV 1, 2018", "OCT 19, 2018", "OCT 8, 2018", "OCT 5, 2018", "AUG 3, 2018", "APR 29, 2018", "DEC 24, 2018", "JUL 26, 2017", "MAY 5, 2017", "MAR 6, 2017", "FEB 16, 2017", "NOV 2, 2016", "OCT 28, 2016", "OCT 28, 2016", "FEB 1, 2018", "JUL 26, 2017", "APR 21, 2016", "APR 21, 2016", "APR 19, 2016", "APR 15, 2016", "APR 15, 2016", "APR 12, 2016", "OCT 28, 2016", "MAR 24, 2016", "MAR 21, 2016", "MAR 21, 2016", "MAR 3, 2016", "FEB 29, 2016", "OCT 15, 2015", "OCT 5, 2015", "MAR 29, 2016", "MAY 28, 2015", "MAY 7, 2015", "APR 23, 2015", "APR 9, 2015", "MAR 26, 2015", "MAR 23, 2015", "MAR 11, 2015", "SEP 23, 2015", "NOV 3, 2014", "SEP 19, 2014", "SEP 16, 2014", "SEP 10, 2014", "SEP 4, 2014", "AUG 28, 2014", "AUG 22, 2014", "MAR 2, 2015", "AUG 19, 2014", "AUG 19, 2014", "AUG 18, 2014", "AUG 12, 2014", "AUG 11, 2014", "AUG 8, 2014", "AUG 8, 2014", "AUG 22, 2014", "AUG 5, 2014", "AUG 1, 2014", "JUL 31, 2014", "JUL 31, 2014", "JUL 28, 2014", "APR 10, 2014", "APR 8, 2014", "AUG 6, 2014", "AUG 5, 2014", "MAR 13, 2014", "OCT 30, 2013", "OCT 30, 2013", "SEP 18, 2013", "JUL 2, 2013", "JUN 21, 2013", "APR 4, 2014", "JUN 14, 2013", "JUN 13, 2013", "JUN 11, 2013", "MAY 31, 2013", "MAY 28, 2013", "MAY 23, 2013", "MAY 22, 2013", "JUN 17, 2013", "JUN 14, 2013", "MAY 17, 2013", "MAY 16, 2013", "MAY 13, 2013", "MAY 10, 2013", "MAY 10, 2013", "SEP 10, 2012", "MAY 21, 2013", "OCT 18, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/atricure-inc-atrc-q1-2020-earnings-call-transcript-2020-04-30", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-tndm-mu-atrc-2020-04-29", "https://www.nasdaq.com/articles/how-the-pieces-add-up%3A-ihi-targets-%24282-2020-04-29", "https://www.nasdaq.com/articles/atricure-atrc-shares-cross-below-200-dma-2020-03-12", "https://www.nasdaq.com/articles/atricure-inc-atrc-q4-2019-earnings-call-transcript-2020-02-19", "https://www.nasdaq.com/articles/atricure-hits-all-time-high-what-next-2020-01-30", "https://www.nasdaq.com/articles/atricure-inc-atrc-q3-2019-earnings-call-transcript-2019-10-31", "https://www.nasdaq.com/articles/commit-to-buy-atricure-at-%2417.50-earn-5.1-annualized-using-options-2019-10-16", "https://www.nasdaq.com/articles/atricure-inc-atrc-q1-2020-earnings-call-transcript-2020-04-30", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-hd-ibm-atrc-2019-08-09", "https://www.nasdaq.com/articles/implied-ihi-analyst-target-price%3A-%24261-2019-08-06", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-atrc-2019-08-05", "https://www.nasdaq.com/articles/atricure-inc-atrc-q2-2019-earnings-call-transcript-2019-07-31", "https://www.nasdaq.com/articles/atrc-crosses-above-key-moving-average-level-2019-06-25", "https://www.nasdaq.com/articles/atricure-inc-atrc-q1-2019-earnings-call-transcript-2019-04-26", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-xent-afl-atrc-2019-03-15", "https://www.nasdaq.com/articles/atricure-is-now-oversold-atrc-2019-08-15", "https://www.nasdaq.com/articles/atricure-inc-atrc-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/analysts-estimate-atricure-atrc-to-report-a-decline-in-earnings%3A-what-to-look-out-for-0", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-sptn-atrc-win-2019-02-19", "https://www.nasdaq.com/articles/atricure-atrc-upgraded-to-strong-buy%3A-heres-what-you-should-know-2019-01-31", "https://www.nasdaq.com/articles/notable-thursday-option-activity-lad-ba-atrc-2019-01-17", "https://www.nasdaq.com/articles/commit-purchase-atricure-25-earn-86-annualized-using-options-2019-01-04", "https://www.nasdaq.com/articles/perrigo-stock-up-as-appeal-date-for-irish-tax-bill-nears-2018-12-27", "https://www.nasdaq.com/articles/atrc-crosses-below-key-moving-average-level-2019-03-04", "https://www.nasdaq.com/articles/atrc-crosses-below-key-moving-average-level-2018-12-20", "https://www.nasdaq.com/articles/atricure-atrc-reports-q3-loss-tops-revenue-estimates-2018-11-01", "https://www.nasdaq.com/articles/analysts-anticipate-ihi-will-reach-237-2018-10-19", "https://www.nasdaq.com/articles/atricure-atrc-looks-good%3A-stock-adds-6.8-in-session-2018-10-08", "https://www.nasdaq.com/articles/why-chefs-warehouse-smart-global-holdings-and-atricure-jumped-today-2018-10-05", "https://www.nasdaq.com/articles/atricure-reaches-analyst-target-price-2018-08-03", "https://www.nasdaq.com/articles/weighing-week-ahead-will-strong-economic-data-send-interest-rates-higher-2018-04-29", "https://www.nasdaq.com/articles/perrigo-plunges-on-%241.9b-tax-bill-from-irish-government-2018-12-24", "https://www.nasdaq.com/articles/perkins-capital-management-inc-buys-amerisourcebergen-corp-pentair-plc-zagg-inc-sells-2017", "https://www.nasdaq.com/articles/heres-why-articure-inc-double-digits-today-2017-05-05", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-deutsche-bank-plans-raise-capital-2017-03-06", "https://www.nasdaq.com/articles/first-light-asset-management-llc-buys-immunomedics-neogenomics-shire-plc-sells-bioscrip", "https://www.nasdaq.com/articles/atricure-atrc%3A-moving-average-crossover-alert-2016-11-02", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-mastercard-beats-q3-views-2016-10-28", "https://www.nasdaq.com/articles/health-care-sector-update-10282016-ehthatrcopxa-2016-10-28", "https://www.nasdaq.com/articles/commit-buy-atricure-1250-earn-86-annualized-using-options-2018-02-01", "https://www.nasdaq.com/articles/perkins-capital-management-inc-buys-amerisourcebergen-corp-pentair-plc-zagg-inc-sells-2017", "https://www.nasdaq.com/articles/stryker-syk-beats-on-q1-earnings-sales-fy16-view-up-2016-04-21", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-april-21st-2016-04-21", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-april-19th-2016-04-19", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-april-15th-2016-04-15", "https://www.nasdaq.com/articles/what-falling-estimates-price-mean-for-insys-therapeutics-insy-2016-04-15", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-april-12th-2016-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-10282016-cytkatrcopxa-2016-10-28", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-march-24th-2016-03-24", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-march-21st-2016-03-21", "https://www.nasdaq.com/articles/phibro-animal-health-pahc-in-focus%3A-stock-jumps-5.1-2016-03-21", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-march-3rd-2016-03-03", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-february-29th-2016-02-29", "https://www.nasdaq.com/articles/3-medtech-stocks-poised-to-trump-earnings-in-q3-2015-10-15", "https://www.nasdaq.com/articles/health-care-sector-update-10052015-atrcctrvgildsien-2015-10-05", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-march-29th-2016-03-29", "https://www.nasdaq.com/articles/atricure-atrc%3A-strong-industry-solid-earnings-estimate-revisions-tale-of-the-tape-2015-05", "https://www.nasdaq.com/articles/can-atricure-atrc-run-higher-on-strong-earnings-estimate-revisions-tale-of-the-tape-2015", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-thursday-tale-of-the-tape-2015-04-23", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-thursday-tale-of-the-tape-2015-04-09", "https://www.nasdaq.com/articles/atricure-atrc-is-overbought%3A-is-a-drop-coming-tale-of-the-tape-2015-03-26", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-monday-tale-of-the-tape-2015-03-23", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-wednesday-tale-of-the-tape-2015-03-11", "https://www.nasdaq.com/articles/atricure-atrc-in-focus%3A-stock-tumbles-10.2-2015-09-23", "https://www.nasdaq.com/articles/strength-seen-in-atricure-atrc%3A-stock-gains-6.6-tale-of-the-tape-2014-11-03", "https://www.nasdaq.com/articles/quidel-corp.-qdel-in-focus%3A-stock-moves-6.73-higher-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/alere-alr-surges%3A-stock-moves-12.4-higher-tale-of-the-tape-2014-09-16", "https://www.nasdaq.com/articles/chimerix-cmrx-in-focus%3A-stock-surges-11.8-tale-of-the-tape-2014-09-10", "https://www.nasdaq.com/articles/tg-therapeutics-tgtx-worth-watching%3A-stock-up-9.1-tale-of-the-tape-2014-09-04", "https://www.nasdaq.com/articles/zimmer-down-to-sell-on-falling-estimate-revisions-view-cut-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/liberator-medical-holdings-lbmh-jumps%3A-stock-gains-6.3-tale-of-the-tape-2014-08-22", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-monday-tale-of-the-tape-2015-03-02", "https://www.nasdaq.com/articles/resmed-introduces-airsense-10-devices-to-treat-sleep-apnea-analyst-blog-2014-08-19", "https://www.nasdaq.com/articles/lemaitre-vascular-acquires-omniflow-ii-manufacturer-xenotis-analyst-blog-2014-08-19", "https://www.nasdaq.com/articles/weakness-seen-in-hanger-hgr-estimates%3A-should-you-stay-away-tale-of-the-tape-2014-08-18", "https://www.nasdaq.com/articles/resmed-rmd-launches-air-solutions-for-improved-sdb-therapy-analyst-blog-2014-08-12", "https://www.nasdaq.com/articles/medtronic-up-on-quadripolar-lead-crt-d-devices-fda-approval-analyst-blog-2014-08-11", "https://www.nasdaq.com/articles/hanger-misses-on-q2-earnings-and-revenues-trims-guidance-analyst-blog-2014-08-08", "https://www.nasdaq.com/articles/falling-earnings-estimates-signal-weakness-ahead-for-tg-therapeutics-tgtx-tale-of-the-tape", "https://www.nasdaq.com/articles/covidiens-first-technology-center-in-brazil-shares-gain-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/alere-q2-earnings-and-revenues-miss-deteriorate-y-y-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/haemonetics-tops-q1-earnings-and-revenues-guidance-retained-analyst-blog-2014-08-01", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-07-31", "https://www.nasdaq.com/articles/hospira-inc.-hsp-jumps%3A-stock-adds-8.3-in-session-tale-of-the-tape-2014-07-31", "https://www.nasdaq.com/articles/atricure-atrc-jumps%3A-stock-adds-6.7-in-session-tale-of-the-tape-2014-07-28", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-thursday-tale-of-the-tape-2014-04-10", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-tuesday-tale-of-the-tape-2014-04-08", "https://www.nasdaq.com/articles/symmetry-medical-tops-on-earnings-revenues-vends-oem-biz-analyst-blog-2014-08-06", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-wednesday-tale-of-the-tape-2014-03-19", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-thursday-tale-of-the-tape-2014-03-13", "https://www.nasdaq.com/articles/healthcare-stocks-adding-earlier-losses-atricure-jumps-nearly-12-after-q3-eps-revenue", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-30-0", "https://www.nasdaq.com/articles/atricure-inc.-atrc-enters-overbought-territory-tale-of-the-tape-2013-09-18", "https://www.nasdaq.com/articles/good-news-for-hospira-shares-up-analyst-blog-2013-07-02", "https://www.nasdaq.com/articles/positive-data-for-covs-pipeline-analyst-blog-2013-06-21", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-friday-tale-of-the-tape-2014-04-04", "https://www.nasdaq.com/articles/abbott-progresses-with-absorb-in-japan-analyst-blog-2013-06-14", "https://www.nasdaq.com/articles/fda-nod-for-stjs-ellipse-assura-analyst-blog-2013-06-13", "https://www.nasdaq.com/articles/symmetry-provides-dismal-2013-view-analyst-blog-2013-06-11", "https://www.nasdaq.com/articles/abbott-labs-hpv-test-in-canada-analyst-blog-2013-05-31", "https://www.nasdaq.com/articles/back-to-neutral-on-hospira-analyst-blog-2013-05-28", "https://www.nasdaq.com/articles/covidiens-enb-adopted-by-accp-analyst-blog-2013-05-23", "https://www.nasdaq.com/articles/ce-mark-for-abbotts-xience-xpedition-48-analyst-blog-2013-05-22", "https://www.nasdaq.com/articles/positive-data-for-covs-solitaire-analyst-blog-2013-06-17", "https://www.nasdaq.com/articles/abbott-progresses-with-absorb-in-japan-analyst-blog-2013-06-14", "https://www.nasdaq.com/articles/stryker-reiterated-at-neutral-analyst-blog-2013-05-17", "https://www.nasdaq.com/articles/covidien-prices-senior-notes-analyst-blog-2013-05-16", "https://www.nasdaq.com/articles/ce-mark-for-stjs-ellipse-assura-analyst-blog-2013-05-13", "https://www.nasdaq.com/articles/stryker-hits-new-52-week-high-analyst-blog-2013-05-10", "https://www.nasdaq.com/articles/st.-jude-reiterated-at-neutral-analyst-blog-2013-05-10", "https://www.nasdaq.com/articles/weekly-ceo-sells-highlight-amyris-atricure-3d-systems-corporation-and-cooper-tire-2012-09", "https://www.nasdaq.com/articles/fda-nod-for-covs-advanced-nellcor-analyst-blog-2013-05-21", "https://www.nasdaq.com/articles/biotech-ma-analyst-gives-5-potential-targets-biomedical-devices-2011-10-18"], "Content": []}